Skip to content

Efficacy and safety of the active bone anchoring hearing aid (Osia2)

Efficacy and safety of the active bone anchoring hearing aid (Osia2) in conductive hearing loss

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0007613
Enrollment
10
Registered
2022-08-05
Start date
2025-02-24
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : The patient undergo the implantation of active bone conduction hearing aid (Osia 2). The surgery will performed under the general anesthesia, about 2 hours, by otol

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Adult patients over 18 years old and under 80 years old ? Mixed hearing loss patient who have bone conduction threshold under 55dB and air-bone gap over 25dB, in pure tone audiometry ? PBmax is over 50% in speech audiometry ? The patients who have difficult to expect hearing improvement with ossiculoplasty ? The patients who can't wear a hearing aid due to not enough gain, otorrhea, and external auditory canal deformity ? The patients who are uncomfortable with the hearing aid they are wearing and want a different hearing rehabilitation method

Exclusion criteria

Exclusion criteria: ? Those who cannot read the consent form or have difficulty understanding the clinical trial due to mental status, illiterate or foreigners ? Patients with no residual hearing or with speech discrimination ability of 50% or less ? Patients who are expected to have sufficient hearing improvement with the use of general hearing aids ? Patients who need other treatment for suspected inner ear and auditory nerve pathway problems

Design outcomes

Primary

MeasureTime frame
Pure tone audiometry and speech audiometry with or without the active bone conduction hearing aid.

Secondary

MeasureTime frame
Adverse reactions after surgery (surgical site infection, device failure, other side effects, etc.)

Countries

Korea, Republic of

Contacts

Public ContactYe Seul Kim

Asan Medical Center

wd11111@naver.com+82-2-3010-3711

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026